WHITEHAWK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $5.56 per share as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $5.56.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.27.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.31.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.80.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $5.56 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $6.27 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $6.31 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $6.80 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $6.90 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $9.72 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $10.82 10-K · filed 2026-03-12 | |
| 2024-09-30 | $10.99 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $11.05 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $11.68 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $14.11 10-K · filed 2025-03-28 | |
| 2023-09-30 | $15.32 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $15.50 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $16.51 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $19.28 10-K · filed 2024-03-13 | |
| 2022-09-30 | $19.85 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $19.84 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $20.88 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $20.71 10-K · filed 2023-03-29 | |
| 2021-09-30 | $20.33 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.80 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $1.83 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.11 10-K · filed 2022-03-17 | $1.81 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.80 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.80 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.85 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.60 10-K · filed 2021-03-11 | |
| 2019-09-30 | $2.62 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.62 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.52 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.73 10-K · filed 2021-03-11 | |
| 2018-09-30 | $3.73 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $3.72 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.74 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $3.72 10-K · filed 2020-03-16 | |
| 2017-09-30 | $1.70 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.70 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.70 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.70 10-K · filed 2019-03-07 | |
| 2015-12-31 | $1.66 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |